378 results match your criteria Telogen Effluvium


Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection.

JAAD Case Rep 2021 Jun 6. Epub 2021 Jun 6.

Albert Einstein College of Medicine, Division of Dermatology, Bronx NY.

View Article and Full-Text PDF

The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study.

Dermatol Pract Concept 2021 May 20;11(3):e2021082. Epub 2021 May 20.

Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.

Background: Androgenetic alopecia is characterized by a progressive miniaturization of hair follicles in a pattern distribution in genetically predisposed individuals. The efficacy of conventional therapies is variable, therefore there is a need for adjuvant and newer treatment modalities to provide faster and better outcomes.

Objectives: Evaluation of vehiculated through iontopthheo ereffsiicsa icny paantdie tnotlse rwaibtihli tayn odfr ao gceonmebtiicn aeldo tpheecriaap ayn: dp raesfsoorcmiaetded g rteolwogthe nfa ecftfolursvium, to obtain faster hair regrowth. Read More

View Article and Full-Text PDF

Clinicopathological insight into self-reported hair loss with no findings: How do we manage this enigmatic condition?

J Dermatol 2021 Jun 12. Epub 2021 Jun 12.

Department of Dermatology, Faculty of Medicine, Kyorin University, Tokyo, Japan.

Patients who complain of hair loss without any supportive findings can be encountered in daily practice. To provide insight into this embarrassing condition, we retrospectively reviewed medical charts of eight cases with self-reported hair loss with no findings (SHLNOF). High frequency in middle aged women and concomitance of thyroid and gynecological problems were revealed. Read More

View Article and Full-Text PDF

Adult skin acute stress responses to short-term environmental and internal aggression from exposome factors.

J Eur Acad Dermatol Venereol 2021 Jun 2. Epub 2021 Jun 2.

Department of Psychosomatic Medicine and Psychotherapy, Justus-Liebig University Gießen, Germany and Charité Center 12 (CC12) for Internal Medicine and Dermatology, Berlin, Germany.

Exposome factors that lead to stressed skin can be defined as any disturbance to homeostasis from environmental (meteorological factors, solar radiation, pollution or tobacco smoke) and/or internal exposure (unhealthy diet, hormonal variations, lack of sleep, psychosocial stress). The clinical and biological impact of chronic exposome effects on skin functions has been extensively reviewed, whereas there is a paucity of information on the impact of short-term acute exposure. Acute stress, which would typically last minutes to hours (and generally no more than a week), provokes a transient but robust neuroendocrine-immune and tissue remodeling response in the skin and can alter the skin barrier. Read More

View Article and Full-Text PDF

Bariatric Surgery-Induced Telogen Effluvium (Bar SITE): Case Report and a Review of Hair Loss Following Weight Loss Surgery.

Cureus 2021 Apr 21;13(4):e14617. Epub 2021 Apr 21.

Dermatology, San Diego Family Dermatology, National City, USA.

Bariatric surgery is a potential modality for the management of obesity. Bariatric patients may experience skin disorders and hair loss postoperatively. A 24-year-old woman with polycystic ovarian syndrome-associated obesity successfully underwent bariatric surgery. Read More

View Article and Full-Text PDF

Association between stress and bilateral symmetrical alopecia in free-ranging Formosan macaques in Mt. Longevity, Taiwan.

Sci Rep 2021 May 27;11(1):11189. Epub 2021 May 27.

Department of Veterinary Medicine, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, 912, Taiwan, ROC.

Since 2013, a high incidence of bilateral symmetrical alopecia has been observed in free-ranging Formosan macaques (Macaca cyclopis) in Mt. Longevity, Taiwan. We hypothesized that stress induces alopecia in this population. Read More

View Article and Full-Text PDF

Corrigendum: Analysis of Microscopic Examination of Pulled Out Hair in Telogen Effluvium Patients.

Ann Dermatol 2020 Jun 24;32(3):264. Epub 2020 Apr 24.

Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.

[This corrects the article on p. 141 in vol. 32. Read More

View Article and Full-Text PDF

Analysis of Microscopic Examination of Pulled Out Hair in Telogen Effluvium Patients.

Ann Dermatol 2020 Apr 11;32(2):141-145. Epub 2020 Mar 11.

Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.

Background: Telogen effluvium (TE) is characterized by massive hair shedding and results from an abrupt conversion of anagen to telogen. Differentiation of TE with other hair disorders showing massive hair shedding is difficult.

Objective: To evaluate the morphologic characteristics of pulled out hair of TE. Read More

View Article and Full-Text PDF

A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection.

Clin Cosmet Investig Dermatol 2021 16;14:385-387. Epub 2021 Apr 16.

Department of Dermatology, China-Japan Friendship Hospital, Beijing, People's Republic of China.

As the number of COVID-19 cases increasing, more and more patients are concerning about alopecia, a sequela after SARS-CoV-2 infection. We here report a case of a 38-year-old woman with a typical acute telogen effluvium (ATE) after recovery from COVID-19. Read More

View Article and Full-Text PDF

A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study.

Ital J Dermatol Venerol 2021 Apr 21. Epub 2021 Apr 21.

Sacred Heart Catholic University, Rome, Italy.

Background: Androgenetic alopecia (AGA) is the most frequent form of alopecia. Telogen effluvium (TE) is a common form of diffuse hair loss mainly observed in women. The aim of our study was to evaluate the efficacy of a topical trichological treatment containing a new combination of molecules for the treatment of AGA and TE. Read More

View Article and Full-Text PDF

Race, ethnicity, and comorbidities are critical factors in the diagnosis of telogen effluvium during the COVID-19 pandemic.

J Am Acad Dermatol 2021 07 8;85(1):209-211. Epub 2021 Apr 8.

Coney Island Medical Center, Department of Dermatology, Brooklyn, New York; Woodhull Medical Center, Department of Dermatology, Brooklyn, New York; Cumberland Medical Center, Department of Dermatology, Brooklyn, New York. Electronic address:

View Article and Full-Text PDF

Pathobiology questions raised by telogen effluvium and trichodynia in COVID-19 patients.

Exp Dermatol 2021 Apr 10. Epub 2021 Apr 10.

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

View Article and Full-Text PDF

Recent Insight on the Management of Lupus Erythematosus Alopecia.

Clin Cosmet Investig Dermatol 2021 30;14:333-347. Epub 2021 Mar 30.

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Lupus erythematosus (LE) is a chronic autoimmune condition with a wide spectrum of clinical presentations. Alopecias, both non-scarring and scarring, frequently occur in the context of LE and can assume several different patterns. Furthermore, alopecia occurring with LE may be considered LE-specific if LE-specific features are present on histology; otherwise, alopecia is considered non-LE-specific. Read More

View Article and Full-Text PDF

Results of low-level laser therapy in the treatment of hair growth: An Egyptian experience.

Dermatol Ther 2021 May 17;34(3):e14940. Epub 2021 Apr 17.

Dermatology, Venereology and Andrology Department, Zagazig University, Zagazig, Egypt.

Recently, low level laser therapy was evaluated as an effective stimulating hair growth. Hair loss is the most common complaint in dermatology (specially females). It causes a significant psychosocial distress and decreased quality of life in affected patients and exists in different types, but the most common types are androgenetic alopecia and telogen effluvium (TE). Read More

View Article and Full-Text PDF

Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.

J Eur Acad Dermatol Venereol 2021 Jul 23;35(7):1485-1492. Epub 2021 Mar 23.

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Topical minoxidil has been used for many years as treatment for different hair disorders. Even though it is an effective therapy, many patients show poor compliance due to the cosmesis, cost and side-effects. During the last few years, low-dose oral minoxidil has proven to be an alternative for patients with alopecia. Read More

View Article and Full-Text PDF

Telogen effluvium in the new SARS-CoV-2 era.

Int J Dermatol 2021 Jul 4;60(7):e265-e266. Epub 2021 Mar 4.

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article and Full-Text PDF

Efficacy of Oral Vitamin D Therapy in Patients Suffering from Diffuse Hair Loss (Telogen Effluvium).

J Nutr Sci Vitaminol (Tokyo) 2021 ;67(1):68-71

Department of Pharmacy, COMSATS University Islamabad.

The aim of the present study was to estimate the prevalence of telogen effluvium (TE) and to evaluate the efficacy of vitamin D in the treatment of this problem in women belonging to various cities of south Punjab, Pakistan. In the present study, 40 adult women suffering from the problem of TE were included. Each woman was treated with oral vitamin D (200,000 IU) therapy fortnightly and a total of 6 doses were given to each patient. Read More

View Article and Full-Text PDF
January 2021

The Diagnostic Value of Serum Ferritin for Telogen Effluvium: A Cross-Sectional Comparative Study.

Clin Cosmet Investig Dermatol 2021 10;14:137-141. Epub 2021 Feb 10.

Department of Dermatology, China-Japan Friendship Hospital, Beijing, People's Republic of China.

Purpose: This study aimed to explore the relationship between serum ferritin levels and telogen effluvium.

Patients And Methods: A total of 193 telogen effluvium patients and 104 female androgenetic alopecia patients were included. We collected the test result of serum ferritin levels, compared with the results of 183 healthy subjects. Read More

View Article and Full-Text PDF
February 2021

Acute Hepatitis and Pancytopenia in a Child With Chronic Abuse of Senna.

Cureus 2021 Jan 2;13(1):e12436. Epub 2021 Jan 2.

Paediatrics, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences, Casablanca, MAR.

Long-term use of Senna and its anthraquinone glycosides has been associated with the development of hepatotoxicity in both children and adults. Our case study aims to present, for the first time, acute hepatitis associated with pancytopenia in relation probably to liver and bone marrow toxicity in a three-year-old child suffering from chronic abuse of Senna. We report the case of a three-year-old girl with a history of chronic constipation regularly treated with drinkable preparations made from the Senna plant and hospitalized eight months ago with an almost similar and reversible clinical presentation, probably of toxic origin. Read More

View Article and Full-Text PDF
January 2021

Telogen Effluvium - a review of the science and current obstacles.

J Dermatol Sci 2021 Mar 23;101(3):156-163. Epub 2021 Jan 23.

National Skin Centre, Singapore; Skin Research Institute of Singapore, Singapore. Electronic address:

Telogen effluvium (TE) is a common cause of diffuse non-scarring hair loss that is usually precipitated by physiological stress such as childbirth or sudden weight loss. Despite its high rate of remission, this phenomenon of sudden excessive hair loss can be very worrisome and upsetting for affected individuals and may significantly impact their quality of life. Due to the multifactorial causes and precipitants of TE, it is often challenging to diagnose and manage. Read More

View Article and Full-Text PDF

Telomere Dynamics and Telomerase in the Biology of Hair Follicles and their Stem Cells as a Model for Aging Research.

J Invest Dermatol 2021 Apr 26;141(4S):1031-1040. Epub 2021 Jan 26.

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA; Centre for Dermatology Research, University of Manchester, Manchester, United Kingdom; Monasterium Laboratory, Münster, Germany.

In this review, we propose that telomere length dynamics play an important but underinvestigated role in the biology of the hair follicle (HF), a prototypic, cyclically remodeled miniorgan that shows an intriguing aging pattern in humans. Whereas the HF pigmentary unit ages quickly, its epithelial stem cell (ESC) component and regenerative capacity are surprisingly aging resistant. Telomerase-deficient mice with short telomeres display an aging phenotype of hair graying and hair loss that is attributed to impaired HF ESC mobilization. Read More

View Article and Full-Text PDF

Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium.

Dermatol Ther 2021 03 7;34(2):e14799. Epub 2021 Feb 7.

Department of Dermatology, University Medical Center Mainz, Mainz, Germany.

Androgenetic alopecia (AGA) with its precursor miniaturization of anagen phase (MA) and telogen effluvium (TE) represent nonscarring hair loss diseases which causes moderate to severe aesthetic and psychologic discomfort in affected people. Several therapeutic approaches have been tested through the latest decades, with different degree of success. In this study we aim to analyze the efficacy and outcome of an innovative therapeutic protocol, named TRICHOBIOLIGHT, a combination of active principles conveyed by mesotherapy directly on the scalp with a subsequent photobiostimulation session with LED light (630 nm). Read More

View Article and Full-Text PDF

Systematic review of platelet-rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability.

Dermatol Ther 2021 03 2;34(2):e14768. Epub 2021 Feb 2.

Department of Dermatology, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran.

Considering the different forms, alopecia could be a very common condition with particular therapeutic concerns; thus, recent therapies still require further assessments. Aim of this systematic review was to evaluate efficacy, safety, and therapeutic durability of platelet rich plasma (PRP) in treating various forms of alopecia. A total of 64 articles were found through a systematic search, and eight original articles were included in the study, based on inclusion/exclusion criteria. Read More

View Article and Full-Text PDF

Telogen effluvium associated with COVID-19 infection.

Dermatol Ther 2021 Mar 14;34(2):e14761. Epub 2021 Jan 14.

Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA.

Telogen effluvium (TE) is characterized by diffuse hair shedding 2-3 months after a stressor, and COVID-19 infection is potentially one such stressor. Those who were infected with the virus were under immense psychosocial and physiologic stress. We retrospectively reviewed electronic medical records of 552 patients who were evaluated by a Henry Ford Health System dermatologist between February 2020 and September 2020 and had a diagnosis of COVID-19 infection. Read More

View Article and Full-Text PDF

Laboratory Testing in Telogen Effluvium.

J Drugs Dermatol 2021 01;20(1):110-111

Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. Read More

View Article and Full-Text PDF
January 2021

The role of sleep in telogen effluvium and trichodynia: A commentary in the context of the current pandemic.

J Cosmet Dermatol 2021 Apr 12;20(4):1088-1090. Epub 2021 Jan 12.

Programa de Pós-Graduação em Medicina Translacional, Universidade Federal de São Paulo (UNIFESP) São Paulo, São Paulo, Brazil.

Telogen effluvium (TE), a common hair disease, is supposed to be related to stress, which could be secondary to poor sleep. We call attention to the current COVID-19 pandemic, that is leading to an increase in the prevalence of sleep disturbances, and as a consequence, higher states of stress and anxiety, which are possible triggers for TE. In parallel, trichodynia is a sensorial symptom that is commonly related with hair diseases, including TE. Read More

View Article and Full-Text PDF

What can the hair tell us about COVID-19?

Exp Dermatol 2021 02 28;30(2):288-290. Epub 2020 Dec 28.

Department of Dermatology, Universidade Federal Fluminense, Centro de Ciências Médicas, Hospital Universitário Antonia Pedro, Niterói - Rio de Janeiro, Brazil.

The novel viral pandemic coronavirus disease 2019 (COVID-19) has sparked uncertainties as to its origin, epidemiology and natural course. The study of the cutaneous manifestations of COVID-19 has evolved with the hope that they may be useful as markers for the disease, prognostication and pathogenic insights into the disease. With regard to the hair, clinicopathological correlations have remained elusive. Read More

View Article and Full-Text PDF
February 2021

Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia.

Skin Appendage Disord 2020 Nov 23;6(6):329-337. Epub 2020 Aug 23.

Department of Dermatology, University of California, Irvine, Irvine, California, USA.

Saw palmetto (SP), a botanical extract with antiandrogenic properties, has gained commercial popularity for its purported benefits on hair regrowth. To summarize published evidence on the efficacy, safety, and tolerability of supplements containing SP in the treatment of alopecia, we conducted a PubMed, Google Scholar, and Cochrane database search using the following terms: (saw palmetto and hair loss), (saw palmetto and androgenetic alopecia), and (saw palmetto and natural supplement and alopecia). Five randomized clinical trials (RCTs) and 2 prospective cohort studies demonstrated positive effects of topical and oral supplements containing SP (100-320 mg) among patients with androgenetic alopecia (AGA) and telogen effluvium. Read More

View Article and Full-Text PDF
November 2020

A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19.

J Am Acad Dermatol 2021 03 10;84(3):773-775. Epub 2020 Dec 10.

Department of Dermatology at Coney Island Medical Center, Brooklyn, NY; Department of Dermatology, New York Medical College, Valhalla, NY. Electronic address:

View Article and Full-Text PDF